Eli Lilly Announces Results From New Analysis Showing Zepbound 10 Mg And 15 Mg, Dual GIP And GLP-1 Receptor Agonist, Delivered Greater Weight Loss Than Wegovy HD In Adults With Obesity

뉴스 본문을 불러오고 있어요.

Eli Lilly Announces Results From New Analysis Showing Zepbound 10 Mg And 15 Mg, Dual GIP And GLP-1 Receptor Agonist, Delivered Greater Weight Loss Than Wegovy HD In Adults With Obesity | 웨이프 WAPE

Eli Lilly Announces Results From New Analysis Showing Zepbound 10 Mg And 15 Mg, Dual GIP And GLP-1 Receptor Agonist, Delivered Greater Weight Loss Than Wegovy HD In Adults With Obesity

기사 요약

관련 종목

댓글 —